SERUM MATRIX METALLOPROTEINASE-9 LEVELS AND CARDIOVASCULAR RISK RATES IN SUBJECTS WITH METABOLIC SYNDROME
ACTA MEDICA MEDITERRANEA, vol.31, no.6, pp.1271-1276, 2015 (SCI-Expanded)
- Publication Type: Article / Article
- Volume: 31 Issue: 6
- Publication Date: 2015
- Journal Name: ACTA MEDICA MEDITERRANEA
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.1271-1276
- Istanbul University Affiliated: No
Abstract
Introduction: The present study aimed to evaluate and to compare Framingham Risk Score (FRS), a prediction tool for 10 year risk of coronary heart disease, and Matrix Metalloproteinase-9 (MMP-9) levels (an atherosclerotic proinflammatory marker) in patients with metabolic syndrome (MetS).